TER
0.49% p.a.
Distribution policy
Accumulating
Replication
Full replication
Fund size
50 m
Holdings
70
Overview
Description
The L&G Healthcare Breakthrough UCITS ETF USD Acc seeks to track the ROBO Global Healthcare Technology and Innovation index. The ROBO Global Healthcare Technology and Innovation index tracks the performance of companies that are actively engaged in the healthcare technology value-chain.
Documents
Chart
Basics
Data
| Index | ROBO Global Healthcare Technology and Innovation |
| Investment focus | Equity, World, Health Care |
| Fund size | GBP 50 m |
| Total expense ratio | 0.49% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Strategy risk | Long-only |
| Sustainability | No |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in GBP) | 17.86% |
| Inception/ Listing Date | 2 July 2019 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ireland |
| Fund Provider | Legal & General (LGIM) |
| Fund Structure | Open-ended Investment Company (OEIC) |
| UCITS compliance | Yes |
| Administrator | BNY Mellon Fund Services (Ireland) Designated Activity Company |
| Investment Advisor | Legal & General Investment Management Limited |
| Custodian Bank | BNY Mellon Trust Company (Ireland) Limited |
| Revision Company | EY |
| Fiscal Year End | 30 June |
| Swiss representative | State Street |
| Swiss paying agent | State Street Bank International GmbH, München, Zweigniederlassung Zürich |
| Germany | 30% tax rebate |
| Switzerland | No ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | BNY Mellon Fund Services (Ireland) Limited |
| Securities lending | No |
| Securities lending counterparty |
Similar ETFs
This section provides you with information on other ETFs with a similar investment focus to the L&G Healthcare Breakthrough UCITS ETF USD Acc.
Similar ETFs via ETF search
Similar ETFs via investment guides
How do you like our ETF profile? Here you'll find our Questionnaire.
Holdings
Below you find information about the composition of the L&G Healthcare Breakthrough UCITS ETF USD Acc.
Top 10 Holdings
Weight of top 10 holdings
out of 70
17.77%
| STAAR Surgical | 1.94% |
| Natera | 1.87% |
| Charles River Labs Intl | 1.78% |
| AxoGen | 1.77% |
| Revvity | 1.77% |
| Danaher Corp. | 1.75% |
| DiaSorin SpA | 1.74% |
| JD Health International | 1.72% |
| Intuitive Surgical | 1.72% |
| Koninklijke Philips NV | 1.71% |
Sectors
| Health Care | 90.04% |
| Consumer Discretionary | 1.72% |
| Technology | 1.47% |
| Other | 6.80% |
As of 27/09/2024
Performance
Returns overview
| YTD | +0.88% |
| 1 month | -1.18% |
| 3 months | -0.86% |
| 6 months | +0.55% |
| 1 year | +11.79% |
| 3 years | -33.24% |
| 5 years | +15.29% |
| Since inception (MAX) | +17.95% |
| 2023 | -8.06% |
| 2022 | -25.30% |
| 2021 | +1.45% |
| 2020 | +60.22% |
Monthly returns in a heat map
Risk
Risk metrics in this section:
- Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
- Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
- Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
Risk overview
| Volatility 1 year | 17.86% |
| Volatility 3 years | 25.00% |
| Volatility 5 years | 25.61% |
| Return per risk 1 year | 0.66 |
| Return per risk 3 years | -0.50 |
| Return per risk 5 years | 0.11 |
| Maximum drawdown 1 year | -8.04% |
| Maximum drawdown 3 years | -45.65% |
| Maximum drawdown 5 years | -51.17% |
| Maximum drawdown since inception | -51.17% |
Rolling 1 year volatility
Stock exchange
Listings
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | XMLH | - - | - - | - |
| Borsa Italiana | EUR | DOCT | DOCT IM DOCEURIV | DOCT.MI DOCTEURINAV=SOLA | Flow Traders B.V. |
| London Stock Exchange | GBX | DOCG | DOCG LN NA | DOCG.L NA | Flow Traders B.V. |
| London Stock Exchange | USD | DOCT | DOCT LN NA | DOCT.L NA | Flow Traders B.V. |
| SIX Swiss Exchange | CHF | DOCT | DOCT SW DOCEURIV | DOCT.S | Flow Traders B.V. |
| XETRA | EUR | XMLH | XMLH GY DOCEURIV | DOCT.DE | Flow Traders B.V. |
Further information
Further ETFs with similar investment focus
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| iShares Healthcare Innovation UCITS ETF | 989 | 0.40% p.a. | Accumulating | Sampling |
| L&G Pharma Breakthrough UCITS ETF | 15 | 0.49% p.a. | Accumulating | Full replication |
| Harbor Health Care UCITS ETF Accumulating | 15 | 0.89% p.a. | Accumulating | Full replication |
| VanEck Genomics and Healthcare Innovators UCITS ETF A | 5 | 0.35% p.a. | Accumulating | Full replication |
| Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | 3 | 0.30% p.a. | Accumulating | Full replication |
Frequently asked questions
What is the name of DOCT?
The name of DOCT is L&G Healthcare Breakthrough UCITS ETF USD Acc.
What is the ticker of L&G Healthcare Breakthrough UCITS ETF USD Acc?
The primary ticker of L&G Healthcare Breakthrough UCITS ETF USD Acc is DOCT.
What is the ISIN of L&G Healthcare Breakthrough UCITS ETF USD Acc?
The ISIN of L&G Healthcare Breakthrough UCITS ETF USD Acc is IE00BK5BC677.
What are the costs of L&G Healthcare Breakthrough UCITS ETF USD Acc?
The total expense ratio (TER) of L&G Healthcare Breakthrough UCITS ETF USD Acc amounts to 0.49% p.a.. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately. Please have a look at our article for more information about the cost of ETFs.
Is L&G Healthcare Breakthrough UCITS ETF USD Acc paying dividends?
L&G Healthcare Breakthrough UCITS ETF USD Acc is an accumulating ETF. This means that dividends are not distributed to investors. Instead, dividends are reinvested in the fund on the ex-date, which leads to an increase of the ETF's share price.
What's the fund size of L&G Healthcare Breakthrough UCITS ETF USD Acc?
The fund size of L&G Healthcare Breakthrough UCITS ETF USD Acc is 50m GBP. See the following article for more information about the size of ETFs.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.